Form 15-12G SpringWorks Therapeutics

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-39044

 

 

SPRINGWORKS THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

 

 

100 Washington Blvd

Stamford, Connecticut 06902

(203) 883-9490

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, par value $0.0001 per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

  

	Rule 12g-4(a)(1)	☒
	Rule 12g-4(a)(2)	☐
	Rule 12h-3(b)(1)(i)	☒
	Rule 12h-3(b)(1)(ii)	☐
	Rule 15d-6	☐
	Rule 15d-22(b)	☐

  

Approximate number of holders of record as of the certification or notice date: One (1)

  

Pursuant to the requirements of the Securities Exchange Act of 1934, SpringWorks Therapeutics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

	SPRINGWORKS THERAPEUTICS, INC.
Date: July 11, 2025	By:	/s/ Michael MacDougall
	Name:	Michael MacDougall
	Title:	Secretary

 

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• A New Jewel on the Las Vegas Strip: Lisa Vanderpump Celebrates Grand Opening of The Vanderpump Hotel
• EXL and Databricks expand collaboration to help enterprises build trusted data foundations for AI
• HEICO Corporation Increases Credit Facility to $2.2 Billion